Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial [ADULT BRAIN]
CONCLUSIONS:
This study shows that dT1 can predict early progression comparable with the standard method but offers the potential for substantial time and cost savings for clinical trials.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Schmainda, K. M., Prah, M. A., Zhang, Z., Snyder, B. S., Rand, S. D., Jensen, T. R., Barboriak, D. P., Boxerman, J. L. Tags: ADULT BRAIN Source Type: research
More News: Avastin | Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Clinical Trials | Neurology | Radiation Therapy | Radiology | Study